Panbela schedules conference call on march 25, 2021 to report 2020 fourth quarter financial results

Minneapolis, march 17, 2021 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced that it will host a conference call on march 25, 2021 at 4:30 pm eastern time to discuss results for its fourth quarter ended december 31, 2020.
PBLA Ratings Summary
PBLA Quant Ranking